Oxford Finance announced that it participated in the issuance of a senior secured credit facility for Linden Capital Partners, a private equity firm that focuses on middle-market leveraged buyout investments in the healthcare and life sciences industries.

Proceeds of the debt financing were used to acquire SeraCare Life Sciences, a global life sciences company that provides products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, as well as to fund ongoing working capital needs.

Oxford acted as syndication agent and lender in the financing.

“Oxford is very pleased to have the opportunity to support Linden Capital Partners’ acquisition of SeraCare Life Sciences,” said Christopher A. Herr, managing director for Oxford Finance. “Linden Capital Partners is a top-tier private equity sponsor, and we look forward to working with them on future transactions.”

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide.